These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16894460)

  • 1. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
    Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
    Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
    Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
    Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
    Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
    Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
    Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
    Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
    Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
    Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression.
    Ohlmann P; Hechler B; Ravanat C; Loyau S; Herrenschmidt N; Wanert F; Jandrot-Perrus M; Gachet C
    J Thromb Haemost; 2008 Jun; 6(6):1003-11. PubMed ID: 18419749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
    Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
    FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.
    Lockyer S; Okuyama K; Begum S; Le S; Sun B; Watanabe T; Matsumoto Y; Yoshitake M; Kambayashi J; Tandon NN
    Thromb Res; 2006; 118(3):371-80. PubMed ID: 16139873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus.
    Takahashi H; Moroi M
    Am J Hematol; 2001 Aug; 67(4):262-7. PubMed ID: 11443641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
    Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
    FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet glycoprotein VI: its structure and function.
    Moroi M; Jung SM
    Thromb Res; 2004; 114(4):221-33. PubMed ID: 15381385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
    Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
    Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
    Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
    Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion.
    Moroi M; Jung SM; Okuma M; Shinmyozu K
    J Clin Invest; 1989 Nov; 84(5):1440-5. PubMed ID: 2808700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments.
    Chu X; Hou M; Peng J; Zhu Y; Zhang F; Ji X; Wang L; Ma D
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):403-7. PubMed ID: 16788317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
    Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
    Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors.
    Coller BS; Folts JD; Smith SR; Scudder LE; Jordan R
    Circulation; 1989 Dec; 80(6):1766-74. PubMed ID: 2598436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.